Oncology & Cancer

Kyprolis approved for multiple myeloma

(HealthDay) -- Kyprolis (carfilzomib) has been approved by the U.S. Food and Drug Administration to treat certain people with multiple myeloma who have already been given at least two prior therapies.

Oncology & Cancer

New test aids personalized cancer care

In a highly successful, first-of-its-kind endeavor, a multidisciplinary team of University of Wisconsin-Madison researchers have created a "tumor in a dish:" an ex vivo microenvironment that can accurately anticipate a multiple ...

Oncology & Cancer

Recommendations presented for MRI use in multiple myeloma

(HealthDay)—Recommendations for the use of magnetic resonance imaging (MRI) in multiple myeloma are presented in a consensus statement published online Jan. 20 in the Journal of Clinical Oncology.

page 8 from 19